<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39452719</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-0817</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>Pathogens (Basel, Switzerland)</Title><ISOAbbreviation>Pathogens</ISOAbbreviation></Journal><ArticleTitle>Consequences of the COVID-19 Pandemic on the Incidence, Management and Outcomes of <i>Staphylococcus aureus</i> Bacteraemia: Experience in a Spanish Hospital.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">847</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/pathogens13100847</ELocationID><Abstract><AbstractText>This work aims to assess the impact of the COVID-19 pandemic on the mortality and incidence of complications in patients with bacteraemia due to <i>Staphylococcus aureus</i> (BSA). All episodes of BSA at the Costa del Sol University Hospital (Marbella, Spain) were recorded during the acute phase of the COVID-19 pandemic (March 2020-March 2022) and compared with those in a previous period (February 2018-February 2020). Demographic, clinical and prognostic variables were recorded. The outcomes were measured as 14- and 30-day mortality and the incidence of complications/death. Mortality during the pandemic was 28.7% at 14 days and 35% at 30 days, while in the pre-pandemic group, it was 18.9% and 23.3%, respectively. For overall complications/deaths, the incidence rate was higher in the pandemic group, with 42.7%. No significant differences were observed between groups. Seventeen patients with COVID-19 were identified, with mortality rates of 64.7% and 70.6% at 14 and 30 days. Multivariate analysis established the presence of sepsis at diagnosis as a predictor of mortality, but not BSA, during the pandemic phase. In conclusion, BSA is a disease with high mortality, which was slightly higher during the pandemic phase. No differences were found in adherence to the bundle in our centre.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lorenzo-Hernández</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Costa del Sol University Hospital, A-7, Km 187, 29603 Marbella, Malaga, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivas-Ruiz</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-8894-0501</Identifier><AffiliationInfo><Affiliation>Research Unit, Costa del Sol University Hospital, A-7, Km 187, 29603 Marbella, Malaga, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Arco-Jiménez</LastName><ForeName>Alfonso</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5432-4591</Identifier><AffiliationInfo><Affiliation>Internal Medicine Department, Costa del Sol University Hospital, A-7, Km 187, 29603 Marbella, Malaga, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pathogens</MedlineTA><NlmUniqueID>101596317</NlmUniqueID><ISSNLinking>2076-0817</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Staphylococcus aureus</Keyword><Keyword MajorTopicYN="N">adherence</Keyword><Keyword MajorTopicYN="N">bacteraemia</Keyword><Keyword MajorTopicYN="N">bundle</Keyword><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">nosocomial</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>10</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39452719</ArticleId><ArticleId IdType="pmc">PMC11510453</ArticleId><ArticleId IdType="doi">10.3390/pathogens13100847</ArticleId><ArticleId IdType="pii">pathogens13100847</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Minter D.J., Appa A., Chambers H.F., Doernberg S.B. Contemporary Management of Staphylococcus aureus Bacteremia—Controversies in Clinical Practice. Clin. Infect. Dis. 2023;77:e57–e68. doi: 10.1093/cid/ciad500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad500</ArticleId><ArticleId IdType="pubmed">37950887</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam J.C., Stokes W. The Golden Grapes of Wrath—Staphylococcus aureus Bacteremia: A Clinical Review. Am. J. Med. 2023;136:19–26. doi: 10.1016/j.amjmed.2022.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2022.09.017</ArticleId><ArticleId IdType="pubmed">36179908</ArticleId></ArticleIdList></Reference><Reference><Citation>Hindy J.R., Quintero-Martinez J.A., Lahr B.D., DeSimone D.C., Baddour L.M. Staphylococcus aureus bacteraemia and mortality: A population-based study in Olmsted County, Minnesota, from 2006 to 2020. Infect. Dis. 2023;55:1–8. doi: 10.1080/23744235.2022.2123561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2022.2123561</ArticleId><ArticleId IdType="pmc">PMC10288387</ArticleId><ArticleId IdType="pubmed">36151989</ArticleId></ArticleIdList></Reference><Reference><Citation>Willekens R., Puig-Asensio M., Suanzes P., Fernández-Hidalgo N., Larrosa M.N., González-López J.J., Rodríguez-Pardo D., Pigrau C., Almirante B. Mortality in Staphylococcus aureus bacteraemia remains high despite adherence to quality indicators: Secondary analysis of a prospective cohort study. J. Infect. 2021;83:656–663. doi: 10.1016/j.jinf.2021.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.10.001</ArticleId><ArticleId IdType="pubmed">34626700</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdollahi A., Nojomi M., Karimi Y., Ranjbar M. Mortality patterns in patients with Staphylococcus aureus bacteremia during the COVID-19 pandemic: Predictors and insights. Heliyon. 2024;10:e24511. doi: 10.1016/j.heliyon.2024.e24511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2024.e24511</ArticleId><ArticleId IdType="pmc">PMC10835178</ArticleId><ArticleId IdType="pubmed">38312595</ArticleId></ArticleIdList></Reference><Reference><Citation>Nambiar K., Seifert H., Rieg S., Kern W.V., Scarborough M., Gordon N.C., Kim H.B., Song K.-H., Tilley R., Gott H., et al. Survival following Staphylococcus aureus bloodstream infection: A prospective multinational cohort study assessing the impact of place of care. J. Infect. 2018;77:516–525. doi: 10.1016/j.jinf.2018.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2018.08.015</ArticleId><ArticleId IdType="pubmed">30179645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikuta K.S., Swetschinski L.R., Robles Aguilar G., Sharara F., Mestrovic T., Gray A.P., Weaver N.D., Wool E.E., Han C., Hayoon A.G., et al. Global mortality associated with 33 bacterial pathogens in 2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400:2221–2248. doi: 10.1016/S0140-6736(22)02185-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)02185-7</ArticleId><ArticleId IdType="pmc">PMC9763654</ArticleId><ArticleId IdType="pubmed">36423648</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Cortes L.E., Del Toro M.D., Galvez-Acebal J., Bereciartua-Bastarrica E., Farinas M.C., Sanz-Franco M., Natera C., Corzo J.E., Lomas J.M., Pasquau J., et al. Impact of an Evidence-Based Bundle Intervention in the Quality-of-Care Management and Outcome of Staphylococcus aureus Bacteremia. Clin. Infect. Dis. 2013;57:1225–1233. doi: 10.1093/cid/cit499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cit499</ArticleId><ArticleId IdType="pubmed">23929889</ArticleId></ArticleIdList></Reference><Reference><Citation>Arientová S., Jícha Z., Beran O., Holub M. Decreased quality of care for Staphylococcus aureus bacteremia during the COVID-19 pandemic. BMC Infect. Dis. 2022;22:631. doi: 10.1186/s12879-022-07607-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07607-9</ArticleId><ArticleId IdType="pmc">PMC9297622</ArticleId><ArticleId IdType="pubmed">35854225</ArticleId></ArticleIdList></Reference><Reference><Citation>Böing C.W., Froböse N.J., Schaumburg F., Kampmeier S. Impact of the COVID-19 Pandemic on the Management of Staphylococcus aureus Bloodstream Infections in a Tertiary Care Hospital. Pathogens. 2023;12:611. doi: 10.3390/pathogens12040611.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens12040611</ArticleId><ArticleId IdType="pmc">PMC10143185</ArticleId><ArticleId IdType="pubmed">37111497</ArticleId></ArticleIdList></Reference><Reference><Citation>Manna S., Baindara P., Mandal S.M. Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2. J. Infect. Public Health. 2020;13:1397–1404. doi: 10.1016/j.jiph.2020.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.07.003</ArticleId><ArticleId IdType="pmc">PMC7359806</ArticleId><ArticleId IdType="pubmed">32712106</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa Pérez M., Fenoll R.G., Bayo S.M., Álvarez R.M.M., Millán V.F., Usón M.C.V., Ruiz M.P.P., Mainar J.M.V., Jiménez M.C.M., Paesa C.R. Impacto de la bacteriemia por Staphylococcus aureus en pacientes con COVID-19. Rev. Esp. Quim. 2022;35:468–474. doi: 10.37201/req/022.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.37201/req/022.2022</ArticleId><ArticleId IdType="pmc">PMC9548065</ArticleId><ArticleId IdType="pubmed">35866373</ArticleId></ArticleIdList></Reference><Reference><Citation>Munro C., Zilberberg M.D., Shorr A.F. Bloodstream Infection in the Intensive Care Unit: Evolving Epidemiology and Microbiology. Antibiotics. 2024;13:123. doi: 10.3390/antibiotics13020123.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics13020123</ArticleId><ArticleId IdType="pmc">PMC10886070</ArticleId><ArticleId IdType="pubmed">38391509</ArticleId></ArticleIdList></Reference><Reference><Citation>Dar S., Erickson D., Manca C., Lozy T., Shashkina E., Kordalewska M., Mediavilla J.R., Chen L., Rojtman A., Kreiswirth B.N. The impact of COVID on bacterial sepsis. Eur. J. Clin. Microbiol. Infect. Dis. 2023;42:1173–1181. doi: 10.1007/s10096-023-04655-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-023-04655-0</ArticleId><ArticleId IdType="pubmed">37597051</ArticleId></ArticleIdList></Reference><Reference><Citation>Serra N., Di Carlo P., Andriolo M., Mazzola G., Diprima E., Rea T., Anastasia A., Fasciana T.M.A., Pipitò L., Capra G., et al. Staphylococcus aureus and Coagulase-Negative Staphylococci from Bloodstream Infections: Frequency of Occurrence and Antimicrobial Resistance, 2018–2021. Life. 2023;13:1356. doi: 10.3390/life13061356.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13061356</ArticleId><ArticleId IdType="pmc">PMC10305610</ArticleId><ArticleId IdType="pubmed">37374138</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque O.I., Shameem M., Hashim W. Secondary infections in critically ill patients with COVID-19: A retrospective single-center study. Lung India. 2023;40:210–214. doi: 10.4103/lungindia.lungindia_293_22.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/lungindia.lungindia_293_22</ArticleId><ArticleId IdType="pmc">PMC10298817</ArticleId><ArticleId IdType="pubmed">37148017</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason E., Nsonwu O., Elmes J., Chudasama D., Pearson C., Hasan L., Hope R., Gerver S.M. Increased rates of hospital-onset Staphylococcus aureus bacteraemia in National Health Service acute trusts in England between June 2020 and March 2021: A national surveillance review. J. Hosp. Infect. 2024;143:33–37. doi: 10.1016/j.jhin.2023.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2023.10.012</ArticleId><ArticleId IdType="pubmed">38529780</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Bastián M., Falces-Romero I., Ramos-Ramos J.C., de Pablos M., García-Rodríguez J., SARS-CoV-2 Working Group Bacterial co-infections in COVID-19 pneumonia in a tertiary care hospital: Surfing the first wave. Diagn. Microbiol. Infect. Dis. 2021;101:115477. doi: 10.1016/j.diagmicrobio.2021.115477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2021.115477</ArticleId><ArticleId IdType="pmc">PMC8254382</ArticleId><ArticleId IdType="pubmed">34358876</ArticleId></ArticleIdList></Reference><Reference><Citation>Nebreda-Mayoral T., Miguel-Gómez M.A., March-Rosselló G.A., Puente-Fuertes L., Cantón-Benito E., Martínez-García A.M., Muñoz-Martín A.B., Orduña-Domingo A. Bacterial/fungal infection in hospitalized patients with COVID-19 in a tertiary hospital in the Community of Castilla y León, Spain. Enferm. Infecc. Microbiol. Clin. 2022;40:158–165. doi: 10.1016/j.eimc.2020.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eimc.2020.11.003</ArticleId><ArticleId IdType="pmc">PMC8847094</ArticleId><ArticleId IdType="pubmed">35216948</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer K.A., Puzniak L.A., Yu K.C., Finelli L., Moise P., Watts J.A., Watts J.A., Gupta V. Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: A multicenter evaluation. BMC Infect. Dis. 2022;22:841. doi: 10.1186/s12879-022-07810-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07810-8</ArticleId><ArticleId IdType="pmc">PMC9651895</ArticleId><ArticleId IdType="pubmed">36368931</ArticleId></ArticleIdList></Reference><Reference><Citation>Adalbert J.R., Varshney K., Tobin R., Pajaro R. Clinical outcomes in patients co-infected with COVID-19 and Staphylococcus aureus: A scoping review. BMC Infect. Dis. 2021;21:985. doi: 10.1186/s12879-021-06616-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06616-4</ArticleId><ArticleId IdType="pmc">PMC8453255</ArticleId><ArticleId IdType="pubmed">34548027</ArticleId></ArticleIdList></Reference><Reference><Citation>Cusumano J.A., Dupper A.C., Malik Y., Gavioli E.M., Banga J., Berbel A.B., Nadkarni D., Obla A., Vasa C.V., Mazo D., et al. Staphylococcus aureus Bacteremia in Patients Infected With COVID-19: A Case Series. Open Forum Infect. Dis. 2020;7:518. doi: 10.1093/ofid/ofaa518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa518</ArticleId><ArticleId IdType="pmc">PMC7686656</ArticleId><ArticleId IdType="pubmed">33269299</ArticleId></ArticleIdList></Reference><Reference><Citation>Asgill T.F., Stupart D. Nosocomial bacterial infections in Victoria decreased during the COVID-19 pandemic. J. Infect. Prev. 2023;24:151–158. doi: 10.1177/17571774231159383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17571774231159383</ArticleId><ArticleId IdType="pmc">PMC9974379</ArticleId><ArticleId IdType="pubmed">37333873</ArticleId></ArticleIdList></Reference><Reference><Citation>Instituto de Estadística y Cartografía de Andalucía—Informe COVID-19 en Andalucía [Internet]  [(accessed on 5 December 2023)].  Available online:  https://www.juntadeandalucia.es/institutodeestadisticaycartografia/badea/informe/datosaldia#79321.</Citation></Reference><Reference><Citation>McCabe W.R., Jackson G.G. Gram-negative bacteriemia. Etiology and ecology. Arch. Lntern. Med. 1962;110:845–855.</Citation></Reference><Reference><Citation>Gudiol F., Aguado J.M., Almirante B., Bouza E., Cercenado E., Domínguez M.Á., Gasch O., Lora-Tamayo J., Miró J.M., Palomar M., et al. Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) Enferm. Infecc. Y Microbiol. Clínica. 2015;33:625.e1–625.e23. doi: 10.1016/j.eimc.2015.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eimc.2015.03.015</ArticleId><ArticleId IdType="pubmed">25937457</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Bayer A., Cosgrove S.E., Daum R.S., Fridkin S.K., Gorwitz R.J., Kaplan S.L., Karchmer A.W., Levine D.P., Murray B.E., et al. Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children. Clin. Infect. Dis. 2011;52:e18–e55. doi: 10.1093/cid/ciq146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciq146</ArticleId><ArticleId IdType="pubmed">21208910</ArticleId></ArticleIdList></Reference><Reference><Citation>Cauhapé V., Lamy B., Lotte R., Touitou I., Boyer L., Contenti J., Parisot F., Ruimy R., Carles M., Courjon J. Lesson from the COVID-19 pandemic lockdown: A major change of hospital-diagnosed bacteremia epidemiology. Infect. Dis. Now. 2023;53:104709. doi: 10.1016/j.idnow.2023.104709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2023.104709</ArticleId><ArticleId IdType="pmc">PMC10085877</ArticleId><ArticleId IdType="pubmed">37044247</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales-Cartagena A., Fernández-Ruiz M., Lalueza A., Lora-Tamayo J., San Juan R., López-Medrano F., Origüen J., Chaves F., Aguado J.M. Impact on mortality of adherence to evidence-based interventions in patients with catheter-related bloodstream infection due to methicillin-sensitive Staphylococcus aureus. Infect. Dis. 2018;50:837–846. doi: 10.1080/23744235.2018.1501513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2018.1501513</ArticleId><ArticleId IdType="pubmed">30325676</ArticleId></ArticleIdList></Reference><Reference><Citation>Escrihuela-Vidal F., Kaasch A.J., Von Cube M., Rieg S., Kern W.V., Seifert H., Song K.-H., Liao C.-H., Tilley R., Gott H., et al. Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: A prospective observational multicentre cohort. Clin. Microbiol. Infect. 2023;29:498–505. doi: 10.1016/j.cmi.2022.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.10.019</ArticleId><ArticleId IdType="pubmed">36283610</ArticleId></ArticleIdList></Reference><Reference><Citation>Falces-Romero I., Bloise I., García-Rodríguez J., Cendejas-Bueno E. Staphylococcus aureus bacteremia in patients with SARS-CoV-2 infection. Med. Clin. 2023;160:495–498. doi: 10.1016/j.medcli.2023.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2023.01.012</ArticleId><ArticleId IdType="pmc">PMC9884619</ArticleId><ArticleId IdType="pubmed">36841646</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>